{
  "ptid_time": "023_S_1190_2011-03-23",
  "img_path": "/data/qiuhui/data/adni/images/023_S_1190/2011-03-23/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 25,205 mm³, 31.8% below the reference mean. With a Z-score of -0.86 (19.5th percentile), this represents normal volume ; whole brain volume measures 940,647 mm³, 1.3% above the reference mean. With a Z-score of 0.16 (56.4th percentile), this represents normal volume . ",
  "text_data": "Age is 80.5 years. Gender is Female. Education: 13 years. Handedness: Right. Race: White. Medical history: Musculoskeletal; Endocrine-Metabolic; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 29.0. MoCA: 25.0. Logical Memory: 19.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.28 SUVR (moderate elevated); Amyloid beta: 1336.00 pg/mL (normal ); Total tau: 439.30 pg/mL (significant elevated); Phosphorylated tau: 40.78 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The patient has normal brain volumes and normal Aβ levels, but elevated T-tau and P-tau, which may indicate neurodegeneration despite preserved cognition (MMSE 29, MoCA 25). The AV45 (amyloid PET) moderate elevation is inconsistent with normal CSF Aβ, requiring further clarification.  \n**Diagnosis:** **MCI** (due to elevated tau biomarkers and slight MoCA decline, but preserved MMSE and no dementia-level impairment).  \n**Confidence:** **Medium** (conflicting biomarker data—tau elevation suggests neurodegeneration, but amyloid status is unclear).",
  "timestamp": "2025-07-26T02:55:59.239698"
}